Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
JPMorgan Asset Management has announced estimated cash distributions for January 2025 across four of its key equity premium income ETFs, providing investors with timely guidance on expected income and important dates.